GlassScriptPhysician profile
Charles Rosenberg
NPI 1134212681
$1,634.06
in general payments reported to CMS, 2019-2025
17 companies · $89.42 in 2025
The $89.42 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $237 · 2021: $413 · 2022: $232 · 2023: $259 · 2024: $176 · 2025: $89.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $524.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $497.43 | 2019-2022 | |
| Lilly USA, LLC | $208.16 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Ucb, INC. | $199.05 | 2021-2024 | Bimzelx, Cimzia |
| Amgen INC. | $166.64 | 2020-2024 | Otezla |
| Sun Pharmaceutical Industries INC. | $111.13 | 2020-2021 | |
| Genzyme Corporation | $67.60 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $67.48 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $61.21 | 2023 | Sotyktu |
| Incyte Corporation | $52.08 | 2023 | Opzelura |
| Janssen Biotech, INC. | $49.41 | 2022-2024 | Tremfya, Simponi Aria, Stelara |
| Arcutis Biotherapeutics, INC. | $30.47 | 2023 | |
| Abbvie INC. | $24.87 | 2024 | |
| Leo Pharma INC. | $24.09 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $20.52 | 2019 | |
| Sensus Healthcare, INC. | $20.00 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dusa Pharmaceuticals, INC. | $18.27 | 2019 | |
| Biofrontera INC. | $15.65 | 2023 | Xepi, Bf-Rhodoled, Ameluz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.